Ackermann Michael 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Aug 10, 2021
Insider Transaction Report
Form 4
Ackermann Michael
Director10% Owner
Transactions
- Sale
Common Stock
2021-08-09$25.00/sh−700$17,500→ 1,227,969 total - Sale
Common Stock
2021-08-06$25.00/sh−3,129$78,225→ 1,228,669 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.